Angiogenic activity of Calendula officinalis flowers L. in rats

Acta Cirurgica Brasileira

Volumn 26, Issue 1, 2011, Pages 19-24

  Parente, Leila Maria Leal ^a   Andrade, Maria Auxiliadora ^a   Brito, Luiz Augusto Batista ^a   De Dignan, Veridiana Maria Souza Brianezi ^a   Miguel, Marina Pacheco ^a   De Lino Jr , Ruy Souza ^a   Tresvenzol, Leonice Faustino Manrique ^a   De Paula, José Realino ^a   Paulo, Neusa Margarida ^a  

^a FEDERAL UNIVERSITY OF GOIÁS   (Brazil)

Author keywords

Calendula; Neovascularization, physiologic; Plants, medicinal; Rats; Wound healing

Indexed keywords

ALCOHOL; CALENDULA EXTRACT; CALENDULA OFFICINALIS EXTRACT; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHICKEN; CHORIOALLANTOIS; CONTROLLED STUDY; EGG; EMBRYO; FEMALE; FLOWER; MARIGOLD; MOUSE; NONHUMAN; PROTEIN EXPRESSION; RAT; SKIN INJURY; VASCULARIZATION;

EID: 79551508656     PISSN: 01028650     EISSN: 16782674     Source Type: Journal    
DOI: 10.1590/S0102-86502011000100005     Document Type: Article

References (16)

1. Re T A, Mooney D, Antignac E, Dufour, E, Bark I, Srinivasan V, Nohynek G. Application of the threshold of toxicological concern approach for thesafety evaluation of calendula flower (Calendula officinalis) petals and extracts used in cosmetic and personal care products. Food Chem Toxicol. 2009;47:1246-54.
2. Pommier P, Gomez F, Sunyach MP, D'Hombres A, Carrie C, Montbarbon X. Phase III randomized trial of Calendula officinalis compared with trolamine for the prevention of acute dermatitis during irradiation for breast cancer. J Clin Oncol. 2004;22:1447-53.
3. Zitterl-Eglseer K, Sosa S, Jurenitsch J, Schubert-Zssilavecz M, Della Loggia R,Tubaro A, Bertoldi M, Franz C. Anti-oedematous activities of the main triterpendiol esters of marigold (Calendula officinalis L.). J Ethnopharmacol. 1997;57:139-44.
4. Brown DJ, Dattner AM. Phytotherapeutic approaches to common dermatologic conditions. Arch Dermatol. 1998;134:1401-4.
5. Della-Loggia R, Tubaro A, Sosa S, Becker H, Isaac O. The role of triterpenoids in the topical anti-inflammatory activity of Calendula officinalis flowers. Planta Med. 1994;60:516-20. (Pubitemid 24382559)
6. Hamburguer M, Adler S, Baumann D, Forg A, Weinreich B. Preparative purification of the major anti-inflammatory triterpenoid ester from Marigold (Calendula officinalis). Fitoterapia. 2003;74:328-38.
7. Hazel SJ. A novel early chorioallantoic membrane assay demonstrates quantitative and qualitative changes caused by antiangiogenic substances. J Lab Clin Med. 2003;141:217-28.
8. RibattiI D, Vacca A, Roncali L, Dammacco F. The chick embryo membrane as model for in vivo research on anti-angiogenesis. Curr Pharmacol Biotechnol. 2000;1:73-82.
9. Farmacopéia Brasileira IV. Atheneu: São Paulo; 2001.
10. Kim MS, Lee YM, Moon EJ, Kim SE, Lee JJ, Kim KW. Anti-angiogenic activity of torilin, a sesquiterpene compound from Torilis japonica. Int J Cancer 2000;87:269-75.
11. Prado FA, Anbinder AL, Jaime, APG, Lima AP, Balducci I, Rocha RF. Defeitos ósseos em tibias de ratos: padronização do modelo experimental. Rev Odontol UNICID. 2006;18(1):7-13.
12. Sampaio IBM. Estatística aplicada à experimentaç ão animal Belo Horizonte: Fundação de Ensino e Pesquisa em Medicina Veterinária; 1998.
13. Moom EJ, Lee YM, Lee OH, Lee MJ, Lee SK, Chung MH. A novel angiogenic factor derived from Aloe vera gel: b-sitosterol, a plant sterol. Angiogenesis. 1999;3:117-23.
14. Hsu S. Green tea and the skin. J Am Acad Dermatol. 2005;52:1049-59.
15. Carmeliet P. Mechanisms of angiogenesis and arteriogenesis: Review. Nature Am. 2000;6(3):389-95.
16. Carmeliet P. Angiogenesis in health and disease: Review. Nature Med. 2003;9(6):653-60.